Sleep Apnea |
Apnea; Apnea, Sleep |
Clinical Trial: Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
This study is currently recruiting patients.
Verified by University Hospital Angers September 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Sleep Apnea Syndrome Nonalcoholic steatohepatitis | Device: nCPAP |
MedlinePlus related topics: Sleep Apnea
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled, Expanded Access Assignment
Official Title: Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: a Prospective Cross Over Trial.
Expected Total Enrollment: 40
Study start: September 2004
Eligibility
Inclusion Criteria:
18 to 70 years old Nonalcoholic steatohepatitis proven by liver biopsy Sleep apnea syndrome proven by polysomnography with an apnea-hypopnea index > 10 events/h Informed consent
Exclusion Criteria:
Psychiatric disorder Other cause of liver disease Professional driver
Location and Contact Information
Frédéric Gagnadoux, Principal Investigator, UH Angers
More Information
Last Updated: September 8, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00152711
Health Authority: France: French General Health Administration
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -


